参考文献/References:
[1] Mathis CA, Holt DP, Wang Y, et al. 11C-labelled thioflavin-T analogues for amyloid plaques imaging in Alzheimer’s disease[J]. J Label Compd Radiopharm, 2001, 44(1):26-28.
[2] Mathis CA, Wang Y, Holt DP, et al. Synthesis and evaluation of 11C-labelled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents[J]. J Med Chem, 2003, 46(13):2740-2754.
[3] Wilson AA, Garcia A, Chestakova A, et al. A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer[11C]6-OH-BTA-1[J]. J Label Compd Radiopharm, 2004, 47:679-682.
[4] Toyama H, Ye D, Ichise M, et al. PET imaging of brain with the β-amyloid probe,[11C]6-OH-BTA-1, in a transgenic mouse of Alzheimer’s disease[J]. Eur J Nucl Med Mol Imaging, 2005, 32(5):593-600.
[5] Klunk WE, Lopresti B J, Ikonomovic MD, et al. Binging of the positron emission tomography tracer Pittsburgh Compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain[J]. J Neurosci, 2005, 25(46):10598-10606.
[6] Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B[J]. Ann Neurol, 2004, 55(3):306-319.
[7] Kemppainen NM, Aalto S, Wilson IA, et al. Voxel-based analysis of PET amyloid ligand[nC]PIB uptake in Alzheimer disease[J]. Neurology, 2006, 67(9):1575-1580.
[8] Mintun MA, Larossa GN, Sheline YI, et al.[11C]PIB in a nondemented population:potential antecedent marker of Alzheimer disease[J]. Neurology, 2006, 67(3):446-452.
[9] Kemppainen NM, Aalto S, Wilson IA, et al. PET amyloid ligand[11C]PIB uptake is increased in mild cognitive impairment[J]. Neurology, 2007, 68(19):1603-1606.
[10] Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B[J]. J Cereb Blood Flow Metab, 2005, 25(11):1528-1547.
[11] Ziolko SK, Weissfeld LA, Klunk WE. Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer’s disease[J]. Neuroimage, 2006, 33(1):94-102.
[12] Edison P, Archer HA, Hinz R,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease:an[11C]PIB and[^18F]FDG PET study[J]. Neurology, 2007, 68(7):501-508.
[13] Scheinin NM, Tolvanen TK, Wilson IA, et al. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans[J]. J Nucl Med, 2007, 48(1):128-133.
相似文献/References:
[1]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[2]段小艺,李淼,王黎,等.阿尔茨海默病PET正电子药物应用与研究进展[J].国际放射医学核医学杂志,2014,38(5):318.[doi:10.3760/cma.j.issn.1673-4114.2014.05.010]
Duan Xiao-yi,Li Miao,Wang Li,et al.Application and research progress of PET positron tracers associated with Alzheimer disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):318.[doi:10.3760/cma.j.issn.1673-4114.2014.05.010]
[3]王新艳,管一晖.阿尔茨海默病的影像学诊断进展[J].国际放射医学核医学杂志,2013,37(1):52.[doi:10.3760/cma.j.issn.1673-4114.2013.01.014]
WANG Xin-yan,GUAN Yi-hui.The advancement in Alzheimer disease of imaging diagnosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):52.[doi:10.3760/cma.j.issn.1673-4114.2013.01.014]
[4]孔艳艳,管一晖,吴平.PET分子探针在阿尔茨海默病早期诊断中的研究进展[J].国际放射医学核医学杂志,2012,36(5):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
KONG Yan-yan,GUAN Yi-hui,WU Ping.Novel PET molecular probes for early diagnosis of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):257.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.001]
[5]王颖,蔡莉,李彦生,等.11C-PIB PET在不同时期阿尔茨海默病中的研究进展[J].国际放射医学核医学杂志,2013,37(6):378.[doi:10.3760/cma.j.issn.1673-4114.2013.06.013]
WANG Ying,CAI Li,LI Yan-sheng,et al.Application of 11C-PIB PET in different period of the Alzheimer disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):378.[doi:10.3760/cma.j.issn.1673-4114.2013.06.013]
[6]张冰,徐俊,徐运,等.fMRI在阿尔茨海默病、额颞叶痴呆及路易体痴呆中的研究进展[J].国际放射医学核医学杂志,2010,34(5):303.[doi:10.3760/cma.j.issn.1673-4114.2010.05.015]
ZHANG Bing,XU Jun,XU Yun,et al.The study of fMRI in Alzheimer’s disease, frontotemporal dementia and Lewy bodies dementia[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):303.[doi:10.3760/cma.j.issn.1673-4114.2010.05.015]
[7]袁瑛,顾兆祥.放射性核素显像在轻度认知功能障碍中的应用价值[J].国际放射医学核医学杂志,2008,32(4):209.
YUAN Ying,GU Zhao-xiang.Applications of radionuclide imaging in mild cognitive impairment[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):209.
[8]郭喆,张锦明.阿尔茨海默病的放射性分子显像探针研究进展[J].国际放射医学核医学杂志,2006,30(4):199.
GUO Zhe,ZHANG Jin-ming.Study on radioactive labeling of molecular probes for Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):199.
[9]蔡汉成,尹端沚,张岚,等.早期诊断阿尔茨海默病的PET分子探针[J].国际放射医学核医学杂志,2006,30(4):202.
CAI Han-cheng,YIN Duan-zhi,ZHANG Lan,et al.PET molecular probes for early detection of Alzheimer’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):202.
[10]李祖贵.轻度认知障碍的功能性神经影像学研究进展[J].国际放射医学核医学杂志,2006,30(2):76.
LI Zu-gui.The progress of functional neuroimaging in the study of mild cognitive impairment[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):76.